{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T11:23:28Z","timestamp":1781263408322,"version":"3.54.1"},"reference-count":26,"publisher":"Journal of Neurosurgery Publishing Group (JNSPG)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,7]]},"abstract":"\n OBJECTIVE<\/jats:title>\n Idiopathic intracranial hypertension (IIH) is a commonly occurring disease, particularly among young women of child-bearing age. The underlying pathophysiology for this disease has remained largely unclear; however, the recent literature suggests that focal outflow obstruction of the transverse sinus may be the cause. The purpose of this study was to report one group\u2019s early experience with transverse venous sinus stenting in the treatment of IIH and assess its effectiveness.<\/jats:p>\n <\/jats:sec>\n \n METHODS<\/jats:title>\n The authors performed a retrospective chart review to identify patients who had undergone stenting of an outflow-obstructed transverse venous sinus for the treatment of IIH at Gates Vascular Institute between January 2015 and November 2017. Patient demographic data of interest included age, sex, BMI, and history of smoking, hypertension, obstructive sleep apnea, hormonal contraceptive use, and acetazolamide therapy. Each patient\u2019s presenting signs and symptoms and whether those symptoms improved with treatment were reviewed. The average opening lumbar puncture (LP) pressure preprocedure, average pressure gradient across the obstructed segment prior to stenting, treatment failure rate (need for shunt placement), and mean follow-up period were calculated.<\/jats:p>\n <\/jats:sec>\n \n RESULTS<\/jats:title>\n \n Of the 18 patients who had undergone transverse venous stenting for IIH, 16 (88.9%) were women. The mean age of all the patients was 38.3 years (median 38 years). Mean BMI was 34.2 kg\/m\n 2<\/jats:sup>\n (median 33.9 kg\/m\n 2<\/jats:sup>\n ). Presenting symptoms were headache (16 patients [88.9%]), visual disturbances (13 patients [72.2%]), papilledema (8 patients [44.4%]), tinnitus (3 patients [16.7%]), and auditory bruit (3 patients [16.7%]). The mean opening LP pressure pre-procedure was 35.6 cm H\n 2<\/jats:sub>\n O (median 32 cm H\n 2<\/jats:sub>\n O). The mean pressure gradient measured proximally and distally to the area of focal obstruction within the transverse sinus was 16.5 cm H\n 2<\/jats:sub>\n O (median 15 cm H\n 2<\/jats:sub>\n O). Postprocedurally, 14 patients (77.8%) continued to have headaches; 6 (33.3%) continued to have visual disturbances. No patients continued to have auditory bruit (0%) or papilledema (0%). One patient (5.6%) had new-onset tinnitus postprocedure. Overall improvement of symptoms was noted in 16 patients (88.9%) postprocedure, with 1 patient (5.6%) requiring shunt placement and 2 other patients (11.1%) requiring postprocedural LP to monitor intracranial pressure to determine candidacy for further surgical interventions to treat residual symptoms. The mean duration of follow-up was 194.2 days.\n <\/jats:p>\n <\/jats:sec>\n \n CONCLUSIONS<\/jats:title>\n Transverse sinus stenting is a rapidly developing technique that has shown good effectiveness and safety in the literature. Authors of the present study found that stenting a flow-obstructed transverse sinus in patients with IIH was a safe and effective way to treat the condition.<\/jats:p>\n <\/jats:sec>","DOI":"10.3171\/2018.5.focus18102","type":"journal-article","created":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T03:37:02Z","timestamp":1530416222000},"page":"E11","source":"Crossref","is-referenced-by-count":43,"title":["Transverse venous stenting for the treatment of idiopathic intracranial hypertension, or pseudotumor cerebri"],"prefix":"10.3171","volume":"45","author":[{"given":"Justin M.","family":"Cappuzzo","sequence":"first","affiliation":[{"name":"Departments of Neurosurgery,"},{"name":"Department of Neurosurgery, Gates Vascular Institute at Kaleida Health;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan M.","family":"Hess","sequence":"additional","affiliation":[{"name":"Jacobs School of Medicine at the University at Buffalo;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John F.","family":"Morrison","sequence":"additional","affiliation":[{"name":"Departments of Neurosurgery,"},{"name":"Department of Neurosurgery, Gates Vascular Institute at Kaleida Health;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason M.","family":"Davies","sequence":"additional","affiliation":[{"name":"Departments of Neurosurgery,"},{"name":"Biomedical Informatics,"},{"name":"Department of Neurosurgery, Gates Vascular Institute at Kaleida Health;"},{"name":"Jacobs Institute, Buffalo, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth V.","family":"Snyder","sequence":"additional","affiliation":[{"name":"Departments of Neurosurgery,"},{"name":"Neurology, and"},{"name":"Department of Neurosurgery, Gates Vascular Institute at Kaleida Health;"},{"name":"Canon Stroke and Vascular Research Center at the University at Buffalo; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elad I.","family":"Levy","sequence":"additional","affiliation":[{"name":"Departments of Neurosurgery,"},{"name":"Radiology,"},{"name":"Department of Neurosurgery, Gates Vascular Institute at Kaleida Health;"},{"name":"Canon Stroke and Vascular Research Center at the University at Buffalo; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adnan H.","family":"Siddiqui","sequence":"additional","affiliation":[{"name":"Departments of Neurosurgery,"},{"name":"Radiology,"},{"name":"Department of Neurosurgery, Gates Vascular Institute at Kaleida Health;"},{"name":"Jacobs Institute, Buffalo, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1754","reference":[{"key":"b1","series-title":"J Neuroophthalmol","first-page":"374","article-title":"Stenting of the transverse sinuses in idiopathic intracranial hypertension","volume":"31","author":"Ahmed R","year":"2011","unstructured":"Ahmed R, Friedman DI, Halmagyi GM: Stenting of the transverse sinuses in idiopathic intracranial hypertension. J Neuroophthalmol 31:374\u2013380, 2011"},{"key":"b2","series-title":"J Neurol Neurosurg Psychiatry","first-page":"488","article-title":"Update on the pathophysiology and management of idiopathic intracranial hypertension","volume":"83","author":"Biousse V","year":"2012","unstructured":"Biousse V, Bruce BB, Newman NJ: Update on the pathophysiology and management of idiopathic intracranial hypertension. J Neurol Neurosurg Psychiatry 83:488\u2013494, 2012"},{"key":"b3","series-title":"Neurol Clin","first-page":"59","article-title":"Venous sinus stenting for idiopathic intracranial hypertension: where are we now?","volume":"35","author":"Dinkin MJ","year":"2017","unstructured":"Dinkin MJ, Patsalides A: Venous sinus stenting for idiopathic intracranial hypertension: where are we now? Neurol Clin 35:59\u201381, 2017"},{"key":"b4","series-title":"J Neuroophthalmol","first-page":"113","article-title":"Venous sinus stenting in idiopathic intracranial hypertension: results of a prospective trial","volume":"37","author":"Dinkin MJ","year":"2017","unstructured":"Dinkin MJ, Patsalides A: Venous sinus stenting in idiopathic intracranial hypertension: results of a prospective trial. J Neuroophthalmol 37:113\u2013121, 2017"},{"key":"b5","series-title":"Arch Neurol","first-page":"875","article-title":"The incidence of pseudotumor cerebri. Population studies in Iowa and Louisiana","volume":"45","author":"Durcan FJ","year":"1988","unstructured":"Durcan FJ, Corbett JJ, Wall M: The incidence of pseudotumor cerebri. Population studies in Iowa and Louisiana. Arch Neurol 45:875\u2013877, 1988"},{"key":"b6","series-title":"J Neuroophthalmol","first-page":"138","article-title":"Idiopathic intracranial hypertension","volume":"24","author":"Friedman DI","year":"2004","unstructured":"Friedman DI, Jacobson DM: Idiopathic intracranial hypertension. J Neuroophthalmol 24:138\u2013145, 2004"},{"key":"b7","series-title":"Neurology","first-page":"1159","article-title":"Revised diagnostic criteria for the pseudotumor cerebri syndrome in adults and children","volume":"81","author":"Friedman DI","year":"2013","unstructured":"Friedman DI, Liu GT, Digre KB: Revised diagnostic criteria for the pseudotumor cerebri syndrome in adults and children. Neurology 81:1159\u20131165, 2013"},{"key":"b8","first-page":"766","article-title":"Pseudotumor cerebri and empty sella syndrome, in Handbook of Neurosurgery","author":"Greenberg MS","year":"2016","unstructured":"Greenberg MS: Pseudotumor cerebri and empty sella syndrome, in Handbook of Neurosurgery, ed 8. New York: Thieme, 2016, pp 766\u2013774"},{"key":"b9","series-title":"Interv Neuroradiol","first-page":"520","article-title":"Endovascular treatment of cerebral venous thrombosis: contemporary multicenter experience","volume":"21","author":"Mokin M","year":"2015","unstructured":"Mokin M, Lopes DK, Binning MJ, Veznedaroglu E, Liebman KM, Arthur AS, : Endovascular treatment of cerebral venous thrombosis: contemporary multicenter experience. Interv Neuroradiol 21:520\u2013526, 2015"},{"key":"b10","series-title":"Arch Neurol","first-page":"78","article-title":"Idiopathic intracranial hypertension (pseudotumor cerebri). Descriptive epidemiology in Rochester, Minn, 1976 to 1990","volume":"50","author":"Radhakrishnan K","year":"1993","unstructured":"Radhakrishnan K, Ahlskog JE, Cross SA, Kurland LT, O\u2019Fallon WM: Idiopathic intracranial hypertension (pseudotumor cerebri). Descriptive epidemiology in Rochester, Minn, 1976 to 1990. Arch Neurol 50:78\u201380, 1993"},{"key":"b11","series-title":"Surv Ophthalmol","first-page":"597","article-title":"Pediatric idiopathic intracranial hypertension","volume":"52","author":"Rangwala LM","year":"2007","unstructured":"Rangwala LM, Liu GT: Pediatric idiopathic intracranial hypertension. Surv Ophthalmol 52:597\u2013617, 2007"},{"key":"b12","series-title":"Curr Treat Options Neurol","first-page":"1","article-title":"Idiopathic intracranial hypertension (pseudotumor cerebri): recognition, treatment, and ongoing management","volume":"15","author":"Thurtell MJ","year":"2013","unstructured":"Thurtell MJ, Wall M: Idiopathic intracranial hypertension (pseudotumor cerebri): recognition, treatment, and ongoing management. Curr Treat Options Neurol 15:1\u201312, 2013"},{"key":"b13","first-page":"1352","article-title":"Pseudotumor cerebri, in Youmans and Winn Neurological Surgery","author":"Winn HR","year":"2016","unstructured":"Winn HR: Pseudotumor cerebri, in Youmans and Winn Neurological Surgery, ed 7. Philadelphia: Elsevier, 2016, pp 1352\u20131364"},{"key":"b1","series-title":"J Neuroophthalmol","first-page":"374","article-title":"Stenting of the transverse sinuses in idiopathic intracranial hypertension","volume":"31","author":"Ahmed R","year":"2011","unstructured":"Ahmed R, Friedman DI, Halmagyi GM: Stenting of the transverse sinuses in idiopathic intracranial hypertension. J Neuroophthalmol 31:374\u2013380, 2011"},{"key":"b2","series-title":"J Neurol Neurosurg Psychiatry","first-page":"488","article-title":"Update on the pathophysiology and management of idiopathic intracranial hypertension","volume":"83","author":"Biousse V","year":"2012","unstructured":"Biousse V, Bruce BB, Newman NJ: Update on the pathophysiology and management of idiopathic intracranial hypertension. J Neurol Neurosurg Psychiatry 83:488\u2013494, 2012"},{"key":"b3","series-title":"Neurol Clin","first-page":"59","article-title":"Venous sinus stenting for idiopathic intracranial hypertension: where are we now?","volume":"35","author":"Dinkin MJ","year":"2017","unstructured":"Dinkin MJ, Patsalides A: Venous sinus stenting for idiopathic intracranial hypertension: where are we now? Neurol Clin 35:59\u201381, 2017"},{"key":"b4","series-title":"J Neuroophthalmol","first-page":"113","article-title":"Venous sinus stenting in idiopathic intracranial hypertension: results of a prospective trial","volume":"37","author":"Dinkin MJ","year":"2017","unstructured":"Dinkin MJ, Patsalides A: Venous sinus stenting in idiopathic intracranial hypertension: results of a prospective trial. J Neuroophthalmol 37:113\u2013121, 2017"},{"key":"b5","series-title":"Arch Neurol","first-page":"875","article-title":"The incidence of pseudotumor cerebri. Population studies in Iowa and Louisiana","volume":"45","author":"Durcan FJ","year":"1988","unstructured":"Durcan FJ, Corbett JJ, Wall M: The incidence of pseudotumor cerebri. Population studies in Iowa and Louisiana. Arch Neurol 45:875\u2013877, 1988"},{"key":"b6","series-title":"J Neuroophthalmol","first-page":"138","article-title":"Idiopathic intracranial hypertension","volume":"24","author":"Friedman DI","year":"2004","unstructured":"Friedman DI, Jacobson DM: Idiopathic intracranial hypertension. J Neuroophthalmol 24:138\u2013145, 2004"},{"key":"b7","series-title":"Neurology","first-page":"1159","article-title":"Revised diagnostic criteria for the pseudotumor cerebri syndrome in adults and children","volume":"81","author":"Friedman DI","year":"2013","unstructured":"Friedman DI, Liu GT, Digre KB: Revised diagnostic criteria for the pseudotumor cerebri syndrome in adults and children. Neurology 81:1159\u20131165, 2013"},{"key":"b8","first-page":"766","article-title":"Pseudotumor cerebri and empty sella syndrome, in Handbook of Neurosurgery","author":"Greenberg MS","year":"2016","unstructured":"Greenberg MS: Pseudotumor cerebri and empty sella syndrome, in Handbook of Neurosurgery, ed 8. New York: Thieme, 2016, pp 766\u2013774"},{"key":"b9","series-title":"Interv Neuroradiol","first-page":"520","article-title":"Endovascular treatment of cerebral venous thrombosis: contemporary multicenter experience","volume":"21","author":"Mokin M","year":"2015","unstructured":"Mokin M, Lopes DK, Binning MJ, Veznedaroglu E, Liebman KM, Arthur AS, : Endovascular treatment of cerebral venous thrombosis: contemporary multicenter experience. Interv Neuroradiol 21:520\u2013526, 2015"},{"key":"b10","series-title":"Arch Neurol","first-page":"78","article-title":"Idiopathic intracranial hypertension (pseudotumor cerebri). Descriptive epidemiology in Rochester, Minn, 1976 to 1990","volume":"50","author":"Radhakrishnan K","year":"1993","unstructured":"Radhakrishnan K, Ahlskog JE, Cross SA, Kurland LT, O\u2019Fallon WM: Idiopathic intracranial hypertension (pseudotumor cerebri). Descriptive epidemiology in Rochester, Minn, 1976 to 1990. Arch Neurol 50:78\u201380, 1993"},{"key":"b11","series-title":"Surv Ophthalmol","first-page":"597","article-title":"Pediatric idiopathic intracranial hypertension","volume":"52","author":"Rangwala LM","year":"2007","unstructured":"Rangwala LM, Liu GT: Pediatric idiopathic intracranial hypertension. Surv Ophthalmol 52:597\u2013617, 2007"},{"key":"b12","series-title":"Curr Treat Options Neurol","first-page":"1","article-title":"Idiopathic intracranial hypertension (pseudotumor cerebri): recognition, treatment, and ongoing management","volume":"15","author":"Thurtell MJ","year":"2013","unstructured":"Thurtell MJ, Wall M: Idiopathic intracranial hypertension (pseudotumor cerebri): recognition, treatment, and ongoing management. Curr Treat Options Neurol 15:1\u201312, 2013"},{"key":"b13","first-page":"1352","article-title":"Pseudotumor cerebri, in Youmans and Winn Neurological Surgery","author":"Winn HR","year":"2016","unstructured":"Winn HR: Pseudotumor cerebri, in Youmans and Winn Neurological Surgery, ed 7. Philadelphia: Elsevier, 2016, pp 1352\u20131364"}],"container-title":["Neurosurgical Focus"],"original-title":[],"link":[{"URL":"https:\/\/thejns.org\/view\/journals\/neurosurg-focus\/45\/1\/article-pE11.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/neurosurg-focus\/45\/1\/article-pE11.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/neurosurg-focus\/45\/1\/article-pE11.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T08:53:43Z","timestamp":1780131223000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejns.org\/view\/journals\/neurosurg-focus\/45\/1\/article-pE11.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":26,"journal-issue":{"issue":"1"},"URL":"https:\/\/doi.org\/10.3171\/2018.5.focus18102","relation":{},"ISSN":["1092-0684"],"issn-type":[{"value":"1092-0684","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7]]}}}